S1 Ep184: Why banning corporate medicine won't save independent practice, with Wayne Winegarden, Ph.D., of the Pacific Research Institute

Off the Chart: A Business of Medicine Podcast · Sep 10, 2026 · 23m · transcript

Thirty-three states now restrict the corporate practice of medicine to some degree, and lawmakers in several more are moving to tighten those limits. Wayne Winegarden, Ph.D., says the crackdown is aimed at the wrong target. Medicare physician payments rose 12% between 2000 and 2022 while the cost of running a practice climbed nearly 48%.

Medical Economics Associate Editor Austin Littrell sat down with Winegarden, a senior fellow in business and economics at the Pacific Research Institute and director of the institute's Center for Medical Economics and Innovation.

Winegarden argues that…